Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check6 days agoChange DetectedA notice about NIH’s terminology transition appears at the top of the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check41 days agoChange DetectedThe record history adds a new revision entry for v3.7.0. The previous revision entry v3.6.6 is removed.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry, v3.6.6, was added to the study record history. The previous revision entry v3.6.5 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedAn additional revision entry, v3.6.5, has been added to the study's history, updating the version list. This change reflects an update to the record's metadata rather than substantive study content.SummaryDifference0.1%

- Check91 days agoChange DetectedThe study record history shows a new revision label from v3.6.3 to v3.6.4. This represents an updated version of the record without altering study content.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.